<SEC-DOCUMENT>0001214659-22-008170-index.html : 20220617
<SEC-HEADER>0001214659-22-008170.hdr.sgml : 20220617
<ACCEPTANCE-DATETIME>20220617165830
ACCESSION NUMBER:		0001214659-22-008170
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220615
FILED AS OF DATE:		20220617
DATE AS OF CHANGE:		20220617

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Kazam Joshua A
		CENTRAL INDEX KEY:			0001221355

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		221024745

	MAIL ADDRESS:	
		STREET 1:		689 5TH AVENUE
		STREET 2:		12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER NAME:	
		FORMER CONFORMED NAME:	KAZAM JOSHUA A
		DATE OF NAME CHANGE:	20070920

	FORMER NAME:	
		FORMER CONFORMED NAME:	KAZAM JOSHOA A
		DATE OF NAME CHANGE:	20030303

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>marketforms-56492.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: marketforms-56492.html

Document 1 - RAW XML: marketforms-56492.xml

</DOCUMENT>
</SEC-DOCUMENT>